The Role of AIM2 Inflammasome in Knee Osteoarthritis
Jiyong Yang,Wengang Liu
DOI: https://doi.org/10.2147/JIR.S392652
IF: 4.5
2022-11-29
Journal of Inflammation Research
Abstract:Jiyong Yang, 1 Wengang Liu 2 1 The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510095, People's Republic of China; 2 Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou, 510095, People's Republic of China Correspondence: Wengang Liu, Orthopedics Department, Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou, 510095, People's Republic of China, Email Knee osteoarthritis (KOA), whose prevalence keeps rising, is still unsolved pathobiological/therapeutical problem. Historically, knee osteoarthritis was thought to be a "wear and tear" disease, while recent etiology hypotheses stressed it as a chronic, low-grade inflammatory disease. Inflammasomes mediated by the innate immunity systems have an important role in inflammatory diseases including KOA. A deluge of recent studies focused on the NLRP3 inflammasome with suggestions that its pharmacologic block would hinder degeneration. However, known inflammasomes are numerous and can also trigger IL-1β/IL-18 production and cells' pyroptotic death. Among them, AIM2 inflammasome is involved in key aspects of various acute and chronic inflammatory diseases. Therefore, while presently leaving out little-studied inflammasomes in KOA, this review focuses on the AIM2 inflammasomes that participate in KOA's complex mechanisms in conjunction with the activation of AIM2 inflammasomes in other diseases combined with the current studies on KOA mechanisms. Although human-specific data about it are relatively scant, we stress that only a holistic view including several inflammasomes including AIM2 inflammasome and other potential pathogenetic drivers will lead to successful therapy for knee osteoarthritis. Keywords: knee osteoarthritis, inflammasome, absent in melanoma 2 Knee osteoarthritis (KOA) is a progressive joint disease that primarily affects the middle-aged and elderly population, with progressive disease progression gradually affecting the patient's mobility and quality of life. 1 Its main pathological feature is the destruction and loss of articular cartilage, but all joint tissues are involved in some form, including subchondral bone remodeling, meniscal degeneration, ligament degeneration and laxity, inflammation and fibrosis of infrapatellar fat pad, synovial inflammation, and periarticular muscle atrophy. 2,3 And in the advanced stages of the disease, eventually leads to the destruction of the entire joint, indicating that KOA is more of a disease that arises from the joint as an organ. Historically, KOA was thought to be a "wear and tear" disease, but it is now considered a multifactorial disease that is not only related to local biomechanical factors of the knee joint, but also involves biochemical factors, including obesity, aging, and gender. 4–6 Among them, the infiltration of a number of proinflammatory cytokines in the joint microenvironment especially the synovial tissues, play an important role in the clinical and pathological progress of KOA. 7–9 Along with the introduction of the concept of osteoimmunology in 2000, 10 increasing studies have shown that immunological mechanisms play a crucial role in the pathogenesis of KOA, especially the innate immune system. 11 Nowadays, KOA is considered a chronic, low-grade inflammatory disease. 12 Anti-inflammatories (NSAIDs and corticosteroids) are typically used to reduce ongoing inflammation and relieve the pain induced by KOA. However, the current treatments can not prevent the sustained release of proinflammatory cytokines. 13,14 The innate immune system is the first line of defense in the body. It can recognize various endogenous and exogenous stimuli in the body through Pattern Recognition receptors (PRRs), including Pathogen-Associated Molecular Patterns (PAMP) and Danger-Associated Molecular Patterns (DAMP), to activate further immune responses. 15 Among them, NOD-like receptors (NLRs) and absent in melanoma 2 (AIM2-like receptors, ALRs) can form a multiprotein structure of the inflammasome in response to various stimuli. 16 The inflammasome converts caspase-1 precursors into active caspase-1, which promotes the maturation and secretion of inflammatory factors: interleukin-1 beta (IL-1β) and interleukin-18 (IL-18), while the activated substances are also involved in cleavage formation and cleavage Gasdermin D (GSDMD), which directly mediates cell death (pyroptosis). 17,18 Under normal conditions, the immune system-mediated inflammatory response is an important function to clear pathogens and maintain homeostasis, but when it is sustained, excessive accumulation and activation can lead to tissue damage in the body. A variety of inflammasomes has been shown to play a role in a variety of dise -Abstract Truncated-
immunology